Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.23 new
Vol. 6, Issue 8 (2017)

Role of adhesion and cytokine related disorders in development and progress of combined arterial hypertension and gout

Author(s):
NG Bychkova and ОА Bychkov
Abstract:

Multiple data available indicate high prevalence of comorbid abnormalities in gouty arthritis patients, namely, high incidence of arterial hypertension, coronary artery disease, stroke, atherosclerosis of carotid arteries, vascular dementia. For instance, hypertension is found in 36-41% gout patients, and combined with metabolic syndrome it may reach 80%. Thesis Objective – studying features of clinical course, lipid profile and immune status in patients with combined hypertension and gout. The study involved examination of 137 male patients with stage II hypertension, average age 56.9±3.4. All patients underwent echocardiography with estimation of the left ventricular mass index to verify hypertension stage, blood chemistry test with estimation of uric acid level, as well as lipid profile and immune status. We have found significant disorders in the lipid profile of blood serum in patients with combined hypertension and gout. Positively higher percentage of activated T-cells was found in patients with combined hypertension and gout, both with early (CD3+CD25+) and late (CD3+HLA-DR+) activation marker, as well as those expressing FAS receptor, and ready to enter into apoptosis. We have identified abnormalities in adhesion and cooperation of immune competent cells, resulting in more intense activation of the same, effector functions and migration to the area of inflammation in the vessel wall.
Pages: 368-371  |  561 Views  14 Downloads
How to cite this article:
NG Bychkova, ОА Bychkov. Role of adhesion and cytokine related disorders in development and progress of combined arterial hypertension and gout. Pharma Innovation 2017;6(8):368-371.
The Pharma Innovation Journal